These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17494054)

  • 21. Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta.
    Kobayashi D; Ieiri I; Hirota T; Takane H; Maegawa S; Kigawa J; Suzuki H; Nanba E; Oshimura M; Terakawa N; Otsubo K; Mine K; Sugiyama Y
    Drug Metab Dispos; 2005 Jan; 33(1):94-101. PubMed ID: 15475413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
    Wang SS; Cozen W; Cerhan JR; Colt JS; Morton LM; Engels EA; Davis S; Severson RK; Rothman N; Chanock SJ; Hartge P
    Cancer Res; 2007 May; 67(10):5042-54. PubMed ID: 17510437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LTA, LEP, and TNF-a Gene Polymorphisms are Associated with Susceptibility and Overall Survival of Diffuse Large B-Cell lymphoma in an Arab Population: A Case-Control Study.
    Al-Khatib SM; Abdo N; Al-Eitan LN; Al-Mistarehi AW; Zahran DJ; Kewan TZ
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2783-2791. PubMed ID: 32986381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative Analysis of the ABCG2 c.421C>A Polymorphism Effect on In Vivo Transport Activity of Breast Cancer Resistance Protein (BCRP) Using an Intestinal Absorption Model.
    Tanaka Y; Kitamura Y; Maeda K; Sugiyama Y
    J Pharm Sci; 2015 Sep; 104(9):3039-48. PubMed ID: 25639366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MDR1 polymorphisms have an impact on the prognosis of Chinese diffuse large B cell lymphoma patients.
    Ni Y; Yin G; Xiao Z; Fan L; Wang L; Wu Y; Wu H; Qian S; Xu W; Li J; Miao K; Qiu H
    Tumour Biol; 2016 Jan; 37(1):1237-44. PubMed ID: 26286835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphisms in ABCG2, ABCC3 and CNT1 genes and their possible impact on chemotherapy outcome of lung cancer patients.
    Müller PJ; Dally H; Klappenecker CN; Edler L; Jäger B; Gerst M; Spiegelhalder B; Tuengerthal S; Fischer JR; Drings P; Bartsch H; Risch A
    Int J Cancer; 2009 Apr; 124(7):1669-74. PubMed ID: 19107936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine.
    Zamber CP; Lamba JK; Yasuda K; Farnum J; Thummel K; Schuetz JD; Schuetz EG
    Pharmacogenetics; 2003 Jan; 13(1):19-28. PubMed ID: 12544509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interindividual variability in the hepatic expression of the human breast cancer resistance protein (BCRP/ABCG2): effect of age, sex, and genotype.
    Prasad B; Lai Y; Lin Y; Unadkat JD
    J Pharm Sci; 2013 Mar; 102(3):787-93. PubMed ID: 23280364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic metabolism and transporter gene variants enhance response to rosuvastatin in patients with acute myocardial infarction: the GEOSTAT-1 Study.
    Bailey KM; Romaine SP; Jackson BM; Farrin AJ; Efthymiou M; Barth JH; Copeland J; McCormack T; Whitehead A; Flather MD; Samani NJ; Nixon J; Hall AS; Balmforth AJ;
    Circ Cardiovasc Genet; 2010 Jun; 3(3):276-85. PubMed ID: 20207952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA repair gene XRCC1 polymorphisms and haplotypes in diffuse large B-cell lymphoma in a Korean population.
    Kim IS; Kim DC; Kim HG; Eom HS; Kong SY; Shin HJ; Hwang SH; Lee EY; Kim S; Lee GW
    Cancer Genet Cytogenet; 2010 Jan; 196(1):31-7. PubMed ID: 19963133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoter hypermethylation of the DNA-repair gene O6-methylguanine-DNA methyltransferase and p53 mutation in diffuse large B-cell lymphoma.
    Hiraga J; Kinoshita T; Ohno T; Mori N; Ohashi H; Fukami S; Noda A; Ichikawa A; Naoe T
    Int J Hematol; 2006 Oct; 84(3):248-55. PubMed ID: 17050200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and Dietary Regulation of Glyburide Efflux by the Human Placental Breast Cancer Resistance Protein Transporter.
    Bircsak KM; Gupta V; Yuen PY; Gorczyca L; Weinberger BI; Vetrano AM; Aleksunes LM
    J Pharmacol Exp Ther; 2016 Apr; 357(1):103-13. PubMed ID: 26850786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphism in IKZF1 gene affects clinical outcome in diffuse large B-cell lymphoma.
    Bielska M; Borowiec M; Jesionek-Kupnicka D; Braun M; Bojo M; Pastorczak A; Kalinka-Warzocha E; Prochorec-Sobieszek M; Robak T; Warzocha K; Młynarski W; Lech-Marańda E
    Int J Hematol; 2017 Dec; 106(6):794-800. PubMed ID: 28879630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males.
    Zhang W; Yu BN; He YJ; Fan L; Li Q; Liu ZQ; Wang A; Liu YL; Tan ZR; Fen-Jiang ; Huang YF; Zhou HH
    Clin Chim Acta; 2006 Nov; 373(1-2):99-103. PubMed ID: 16784736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical implications of glutathione S-transferase genotyping in patients with diffuse large B-cell lymphoma.
    Atanaskovic L; Cikota-Aleksic B; Tarabar O; Trimcev J; Zivanovic-Ivic A; Marjanovic S; Magic Z
    J BUON; 2016; 21(6):1459-1465. PubMed ID: 28039708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A gene-wide investigation on polymorphisms in the ABCG2/BRCP transporter and susceptibility to colorectal cancer.
    Campa D; Pardini B; Naccarati A; Vodickova L; Novotny J; Försti A; Hemminki K; Barale R; Vodicka P; Canzian F
    Mutat Res; 2008 Oct; 645(1-2):56-60. PubMed ID: 18775442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast cancer resistance protein (BCRP/MXR/ABCG2) in adult acute lymphoblastic leukaemia: frequent expression and possible correlation with shorter disease-free survival.
    Suvannasankha A; Minderman H; O'Loughlin KL; Nakanishi T; Ford LA; Greco WR; Wetzler M; Ross DD; Baer MR
    Br J Haematol; 2004 Nov; 127(4):392-8. PubMed ID: 15521915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphotoxin alfa and receptor-interacting protein kinase 1 gene polymorphisms may correlate with prognosis in patients with diffuse large B cell lymphoma treated with R-CHOP.
    Chae YS; Kim JG; Sohn SK; Moon JH; Kim SN; Lee SJ; Park TI; Lee MH
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):571-7. PubMed ID: 19629486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphism in interleukin 21 gene is associated with decreased susceptibility to diffuse large B cell lymphoma.
    Li J; Mai J
    Tumour Biol; 2014 Nov; 35(11):11295-300. PubMed ID: 25117075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The C421A (Q141K) polymorphism enhances the 3'-untranslated region (3'-UTR)-dependent regulation of ATP-binding cassette transporter ABCG2.
    Ripperger A; Benndorf RA
    Biochem Pharmacol; 2016 Mar; 104():139-47. PubMed ID: 26903388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.